At the news
? NEUTRALIMPACT 2/10 8-K filed May 8, 2026 at 16:09 ET
Rocket Lab filed a prospectus supplement to register up to 2,277,002 shares for resale by selling stockholders, which were issued in April 2026 as part of the Mynaric AG acquisition. This is a routine procedural filing to facilitate the resale of shares already outstanding, with no new financial or operational impact.
- Up to 2,277,002 shares registered for resale by selling stockholders
- Shares issued April 14, 2026 in connection with Mynaric AG acquisition
- Filed prospectus supplement under existing S-3ASR registration statement
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access